What question did this study set out to answer?

This study investigates the impact of atrial fibrillation on thrombotic events and survival outcomes in myeloproliferative neoplasm patients.

Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis

View Full Paper

Ask AI

Bookmark

Authors

Real-world analysis reveals higher thrombotic events and shorter survival in patients with MPN and AF, suggesting need for tailored treatment.

This study investigates the impact of atrial fibrillation on thrombotic events and survival outcomes in myeloproliferative neoplasm patients.
Multicenter, real-world retrospective study
Analyzed 2,683 MPN patients from 1976 to 2024
Examined thrombotic events, bleeding risk, and overall survival outcomes
Patients with MPN and atrial fibrillation had a higher thrombotic event rate (67% vs. 43%, p < 0.0001)
AF was linked to shorter overall survival (181 months vs. 265 months, HR: 1.86, 95% CI: 1.53–2.26, p < 0.0001)
36.7% of MPN-AF patients did not receive antiplatelet therapy, despite high thrombosis rates

Demska et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Real-world analysis reveals higher thrombotic events and shorter survival in patients with MPN and AF, suggesting need for tailored treatment.